HONG KONG–(BUSINESS WIRE)–Jul 20, 2021–
CSOP Asset Administration Restricted (“CSOP”) is proud to announce the itemizing of CSOP China Healthcare Disruption Index ETF (inventory ticker: 3174.HK) on the Hong Kong Inventory Trade (the “HKEX”). 3174.HK will observe the efficiency of the Solactive China Healthcare Disruption Index (the “Index”). With itemizing value at round HKD 7.8 per unit, buying and selling lot of 100 shares and annual administration charge of 0.99%, CSOP China Healthcare Disruption Index ETF will begin to commerce on 21 July, 2021. Upon inception, 3174.HK has obtained round HKD 103 million preliminary funding.
This press launch options multimedia. View the complete launch right here: https://www.businesswire.com/news/home/20210719005878/en/
(Graphic: Enterprise Wire)
The healthcare sector incorporates a various array of industries, together with biotechnology, Web-based medical providers, drug discovery and manufacturing providers and plenty of different associated providers. Since Covid-19 hit the world unexpectedly, the healthcare sector has obtained unprecedented consideration. In 2018, international spending on well being reached USD 8.3 trillion, or 10% of worldwide gross home product (GDP). 1 It’s anticipated to extend at an annual fee of 4.9% from 2018 to 2022, attaining USD 10.05 trillion in 2022. 2 At the moment, China has the second-largest healthcare business on this planet. In comparison with a five-year compound annual progress fee (“CAGR”) of 4% in the US, China’s healthcare market has grown quickly at a CAGR of 17%. 3 China’s healthcare market measurement is aimed to broaden to about USD 2.4 trillion by 2030. 4 The onset of Covid-19 together with China’s ageing inhabitants has additional offered appreciable progress alternatives for the healthcare sector, notably in sub-sectors like telemedicine and biotech. Closely featured within the thirteenth 5-12 months Plan and the Wholesome China 2030 technique, Web-based healthcare in China has maintained a excessive CAGR of over 30%. 5 China’s authorities analysis & growth (“R&D”) spending on biotech topped USD 291 billion in 2019, whereas corporations raised USD 16.5 billion throughout 90 fairness and debt choices, representing a 17% enhance in quantity and 13% enhance in worth from 2018. 6
In 2020, the healthcare sector within the Hong Kong inventory market confirmed sturdy progress momentum and obtained important market curiosity with 23 newly listed healthcare corporations elevating a complete of HKD 98 billion. 7 To duplicate the strong efficiency of the fast-growing healthcare business in Better China, the Solactive China Healthcare Disruption Index comprehensively invests in as much as 35 most consultant Hong Kong-listed corporations with enterprise operations in mainland China, Hong Kong, Taiwan and Macau. These corporations deal with numerous revolutionary fields, starting from biotechnology and medical specialties to biopharmaceuticals, and healthcare gear to Web pharmacies and drug retail. Primarily based on historic back-testing knowledge, the Index achieves a return of 36.6% over the prior 12 months. 8 Weighted by free-float market capitalization of constituents, the Index ensures the inclusion of essentially the most consultant corporations in Better China’s healthcare business with a mixed scheme of quarterly rebalance and weekly IPO assessment. As the top of Might 2021, the entire market cap of the index is HKD 2.98 trillion. 9 Primarily adopting a bodily consultant sampling technique to duplicate the index, 3174.HK allows worldwide buyers to understand the funding alternatives of healthcare business in a straightforward and clear approach.
The way forward for human beings embrace a better, greener and more healthy way of life. Because the pioneer ETF issuer in Hong Kong, CSOP has all the time been devoted to offering ETFs/ETPs that not solely serve the calls for of asset allocation, but in addition current the prospects of investments. 3174.HK is without doubt one of the essential members of CSOP future-defining thematic ETFs.
Melody He, Managing Director, Head of Enterprise Growth and Product Technique & Options, says: “We’re delighted to convey one other future-themed ETF to our buyers. The launch of 3174.HK allows buyers to understand the funding alternatives by pursuing a more healthy life extra simply and transparently. Among the many sequence of CSOP future thematic ETFs, CSOP Hold Seng TECH Index ETF (3033.HK), CSOP Yinhua CSI 5G Communications Theme ETF (3193.HK) 10 and CSOP World Cloud Computing Know-how Index ETF(3194.HK) are our solutions to rising demand for a extra clever way of life. CSOP Huatai-Pinebridge CSI Photovoltaic Trade ETF (3134.HK) 11 additional completes a major piece of puzzle for a greener life. Extra CSOP’s future-themed ETFs will come to the market, unfolding the way forward for investments in entrance of buyers.”
About CSOP Asset Administration Restricted
CSOP Asset Administration Restricted (“CSOP”) was based in 2008 as the primary offshore asset supervisor arrange by a regulated asset administration firm in China. With a devoted deal with China investing, CSOP manages private and non-private funds, in addition to offering funding advisory providers to Asian and international buyers. As well as, CSOP is finest often known as an ETF chief in Asia. As of 31 March 2021, CSOP has greater than USD 10 billion in property below administration.
This materials has not been reviewed by the Securities and Futures Fee.
Issuer: CSOP Asset Administration Restricted
Please consult with the providing paperwork for the index supplier disclaimer.
IMPORTANT: Funding includes dangers. Funding worth might rise or fall. Previous efficiency data offered is just not indicative of future efficiency. Traders ought to consult with the Prospectus and the Product Key Details Assertion for additional particulars, together with product options and threat elements. Traders mustn’t base on this materials alone to make funding selections.
CSOP China Healthcare Disruption Index ETF:
- CSOP China Healthcare Disruption Index ETF (the “Sub-Fund”) is just not principal assured and your investments might endure losses. There isn’t a assurance that the Sub-Fund will obtain its funding goal.
- Solactive China Healthcare Disruption Index (the “Index”) is a brand new index. The Sub-Fund could also be riskier than different trade traded funds monitoring extra established indices with longer working historical past
- The Index is topic to geographical focus dangers because of monitoring the efficiency of primarily Hong Kong listed corporations which have enterprise operations within the discipline of healthcare sector in mainland China, Hong Kong, Taiwan and Macau. The worth of the Sub-Fund could also be extra inclined to antagonistic financial, political, coverage, overseas trade, liquidity, tax, authorized or regulatory occasion affecting the Hong Kong market and locations the place these corporations have enterprise operations together with mainland China, Taiwan and Macau
- Dangers related to FDIs embody counterparty/credit score threat, liquidity threat, valuation threat, volatility threat and over-the-counter transaction threat. FDIs are inclined to cost fluctuations and better volatility, and will have giant bid and supply spreads and no energetic secondary markets. The leverage component/element of an FDI can lead to a loss considerably higher than the quantity invested within the FDI by the Sub-Fund. Publicity to FDIs might result in a excessive threat of serious loss by the Sub-Fund
- The buying and selling value of the Shares on the SEHK is pushed by market elements such because the demand and provide of the Shares. Due to this fact, the Shares might commerce at a considerable premium or low cost to the Sub-Fund’s NAV
Please word that the above listed funding dangers usually are not exhaustive and buyers ought to learn the Prospectus and the Product Key Details Assertion intimately earlier than making any funding resolution.
1 Supply: WHO, World Spending on Well being: Weathering the Storm, 2020 2 Supply: Deloitte, 2019 World Healthcare Outlook: Shaping the Future 3 Supply: WHO, 2018 4 Supply: China’s Nationwide Well being and Household Planning Fee (NHFPC) 5 Supply: Frost & Sullivan, 36Kr Analysis, 2012-2026 China’s Web Medical Market Scale and Forecast 6 Supply: Baker McKenzie, The Way forward for Capital Elevating in Biotech and Pharma 7 Supply: HKEX, February 2021 8 Supply: Solactive AG, 29 June 2021 9 Supply: Bloomberg 10 CSOP Yinhua CSI 5G Communications Theme ETF is a feeder fund. Its grasp fund, Yinhua CSI 5G Communication ETF, is just not approved by the Securities and Futures Fee for direct providing to the general public in Hong Kong.
11 CSOP Huatai-PineBridge CSI Photovoltaic Trade ETF is a feeder fund. Its grasp fund, Huatai-PineBridge CSI Photovoltaic Trade ETF, is just not approved by the Securities and Futures Fee for direct providing to the general public in Hong Kong.
View supply model on businesswire.com:https://www.businesswire.com/news/home/20210719005878/en/
CONTACT: CSOP Asset Administration Restricted
Larry Wang / 3406 5613 /firstname.lastname@example.org
Tina Shu/ 3406 email@example.com
KEYWORD: HONG KONG CHINA SINGAPORE ASIA PACIFIC
INDUSTRY KEYWORD: SOFTWARE MANAGED CARE BANKING NETWORKS GENERAL HEALTH INTERNET PROFESSIONAL SERVICES PHARMACEUTICAL TECHNOLOGY BIOTECHNOLOGY FINANCE HEALTH
SOURCE: CSOP Asset Administration Restricted
Copyright Enterprise Wire 2021.
PUB: 07/20/2021 02:30 AM/DISC: 07/20/2021 02:31 AM